Phreesia, Inc. (NYSE:PHR) Receives $31.33 Average Target Price from Analysts

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) have received a consensus rating of "Buy" from the twelve analysts that are covering the company, MarketBeat reports. Twelve equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued a report on the stock in the last year is $31.33.

A number of analysts have recently weighed in on the company. DA Davidson cut their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Needham & Company LLC reaffirmed a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, March 13th. Citigroup upped their price objective on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. KeyCorp cut their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Finally, Canaccord Genuity Group increased their target price on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, March 13th.

Phreesia Trading Down 1.1 %

NYSE:PHR traded down $0.28 during trading hours on Friday, reaching $24.47. 271,203 shares of the stock were exchanged, compared to its average volume of 431,619. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average of $25.41 and a two-hundred day moving average of $24.44. Phreesia has a twelve month low of $17.07 and a twelve month high of $30.53. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of -16.65 and a beta of 0.82.

Insider Transactions at Phreesia

In related news, COO Evan Roberts sold 16,005 shares of the firm's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $30.00, for a total value of $480,150.00. Following the completion of the sale, the chief operating officer now owns 748,302 shares in the company, valued at $22,449,060. This trade represents a 2.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Allison C. Hoffman sold 1,213 shares of the firm's stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $23.81, for a total transaction of $28,881.53. Following the completion of the sale, the general counsel now owns 137,921 shares of the company's stock, valued at approximately $3,283,899.01. The trade was a 0.87 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 113,160 shares of company stock worth $3,139,103. Company insiders own 5.80% of the company's stock.

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently modified their holdings of the company. Charles Schwab Investment Management Inc. raised its holdings in Phreesia by 10.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after purchasing an additional 46,209 shares during the last quarter. Wesbanco Bank Inc. grew its holdings in Phreesia by 76.9% in the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock valued at $1,157,000 after purchasing an additional 20,000 shares during the last quarter. Barclays PLC grew its holdings in Phreesia by 83.6% in the third quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after purchasing an additional 43,225 shares during the last quarter. Franklin Resources Inc. grew its holdings in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock valued at $31,495,000 after purchasing an additional 42,973 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock valued at $28,397,000 after purchasing an additional 55,934 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.